3 levels compared to control shRNAs. It is to be noted that the shFOSL2-2 did not reduce the level of the all FOSL2 isoforms and was not used in Supplementary Data File 2 is a file containing all the browser tracks used in the study.
The ZIP file is accessible using the following URL: https://datahubkazb7g4u.udes.genap.ca/Scientific_Reports/Supplementary_Data_Files/. (ZIP archive containing bigWig files; Size: 7.74 GB)
Supplementary Experimental Procedures
Cell Culture Conditions MCF7 (ATCC, , as well as HEPG2 (ATCC, HB-8065) were grown in DMEM (Gibco, 11965-092) , while A549 (ATCC, CCL-185) were grown in F12K medium (Gibco, 21127022) as recommended by the supplier. All cell mediums were supplemented with 10% fetal bovine serum (Invitrogen, qualified 12483020), 100 μM MEM nonessential amino acids (Cellgro, , 2 mM L-glutamine (Gibco, 25030-081) , 100 U/ml penicillin, 100 μg/ml streptomycin (Gibco, 15170-063) . For ChIP experiments, MCF7 were kept in DMEM w/o phenol-red (Gibco, 31053-028) supplemented with 5% of Charcoal/Dextran treated FBS (Hyclone, AVH78911), 100 μM MEM nonessential amino acids (Cellgro, and 2 mM L-glutamine (Gibco, 25030-081) for 3 days prior to 100nM of Beta-Estradiol (SIGMA, E8875) for two hours.
Chromatin Immunoprecipitation

Antibodies
For MED1 (CRSP1/TRAP220) occupied genomic regions, we performed the ChIP-Seq experiments using the Bethyl Laboratories (A300-793A) antibody. The affinity purified antibody was raised in rabbit against an epitope corresponding to amino acids 1523-1281 mapping at the C-terminus of human MED1. Specificity of the antibody for ChIP-Seq experiments was validated previously 1 . For SMC1A occupied genomic regions, we performed the ChIP-Seq experiments using the Bethyl Laboratories (A300-055A) affinity purified rabbit polyclonal antibody. The epitope recognized by A300-055A maps to a region between residue 1175 and the Cterminus of human SMC1A. Specificity of the antibody for ChIP-Seq experiments was validated previously 1 .
For NIPBL occupied genomic regions, we performed the ChIP-Seq experiments using the Bethyl Laboratories (A301-779A) affinity purified rabbit polyclonal antibody. The affinity purified antibody was raised in rabbit to a region between amino acid residues 1025 and 1075 of human NIPBL. Specificity of the antibody for ChIP-Seq experiments was validated previously 1 .
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For ERa occupied genomic regions, we performed the ChIP-Seq experiments using the Santa Cruz (sc-543x) affinity purified rabbit polyclonal antibody. The affinity purified antibody was raised in rabbit to a region between amino acid residues 1025 and 1075 of human ERa. Specificity of the antibody for ChIP-Seq experiments was validated previously by ENCODE project consortium (https://genome.ucsc.edu/ENCODE/validation/antibodies/human_ERalpha_a_validation _Myers.pdf).
Immunoprecipitation
ChIP (ChIP-qPCR) and ChIP coupled with massively parallel sequencing (ChIP-seq) were performed as previously described 1, 2 . Briefly, cells were crosslinked with 1%
formaldehyde in culture medium for 10 minutes at room temperature. Cells were then lysed in 10 ml lysis buffer (0.1%SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl ph 8.0 and 150 mM NaCl) and chromatin was sheared to 200-600 bp fragments using a Bioruptor Sonicator (Diagenode). Chromatin extract from 5x10 7 cells was incubated overnight at 4 o C with 100 ul of Dynabeads Protein G magnetic beads (Life Technologies, 10004D) previously incubated with 10 ug of selected antibodies (NIPBL (Bethyl, A301-779A), MED1 (Bethyl, A300-793A), SMC1A (Bethyl, A300-055A), ERa (Santa Cruz, sc543X), SMC3 (Bethyl, A300-158A) and SA2 (Bethyl, A300-060A)).
ChIP-qPCR (Fig. 5 and Supplementary Figs S2 and S4)
For single gene analysis, primers were designed in the predicted enhancers and 
Bioinformatics and Analytical Methods
All the ChIP-Seq datasets used in the study (Supplementary Table S2 ) were analyzed with ChIP-Seq pipeline developed at the MUGQIC (version 2.1.0) which is briefly summarized below:
Short-Read pipeline processes
All samples were processed using Trimmomatic 0.33 3 with the following parameters:
LEADING=30, TRAILING=30, SLIDINGWINDOW=4:30, MINLEN=30. ChIP-seq reads were mapped against the hg19 build of the human reference genome using BWA 0.7.12 4 with default parameters. MACS2 2.1.0 5 with default parameters was used for peak calling. All replicates (two replicates for our ChIP-Seq experiments and up to eight for ENCODE datasets) were processed separately until this step.
Data mining and parsing of the metadata ENCODExplorer
(https://www.bioconductor.org/packages/release/bioc/html/ENCODExplorer.html) was used to parse the metadata and retrieve the Fastq files from the ENCODE consortium.
ChIPseeker 6 was used for data mining of data deposited in the GEO database.
Gene annotation
All peak regions defined by MACS2 were annotated using the UCSC database R package used to merge the narrowPeak files generated by MACS2 for all replicates to find the best consensus at a given genomic regions. The following parameters were used: extendingSize = 200, expandToFitPeakRegion = TRUE, shrinkToFitPeakRegion = TRUE.
The extendingSize parameter allows to determine the size of padding on both sides of the position of the peaks median to create the consensus region. The expandToFitPeakRegion parameter allows to extend the consensus regions to include the entire narrow peak regions of all peaks included in the unextended consensus region.
shrinkToFitPeakRegion allow to shrink the consensus regions size to fit the narrow peak regions of the peaks when all those regions are smaller than the consensus region. The minimum number of replicates with a significant enriched region (minNbrExp) was set to 2 out 3 for targets with 3 and more datasets. minNbrExp was set to 2 for targets with 2 biological replicates.
PCA analysis (Fig. 1a) A binary matrix encoding the presence or absence of NIPBL, MED1, SMC1A or CTCF at all genomic loci where at least one factor was present was constructed (Rows: loci;
Columns: ChIP-Seq targets). Principal component analysis (PCA) was performed using the R package FactoMineR (http://CRAN.R-project.org/package=FactoMineR) considering the presence or absence of NIPBL, MED1, SMC1A or CTCF as the variables.
Visualization of the variables on the first two components was performed using a "correlation circle plot" with the factoextra R package (https://github.com/kassambara/factoextra). For the representation, the correlation/loading values are on the 0 to 1 scale, with a value of 1 meaning 100% correlation/loading with the dimension. The density of loci was calculated as the projection of the loci coordinates onto the first dimension (which discriminated the most the loci with CTCF and without CTCF). The y-axis is scaled to one unit and the x-axis is an arbitrary unit representing the coordinates of the loci on the first dimension. Each group (No signal, SMC1A (no CTCF), and SMC1A (with CTCF)) was assigned a color.
Browser tracks (Figs 1b and 3c)
BigWig files were generated by using Samtools Overlaps with chromatin states (Fig. 1c,d) The 18 chromatin states for HEPG2 and A549 were retrieved from the consortium Epigenomic Roadmap. The chromatin states were generated with ChromHMM 8,9 with a core set of 6 chromatin marks (H3K4me3, H3K4me1, H3K36me3, H3K27me3, H3K27ac, Once the chromatin states were defined, the ratio of nucleotides from each chromatin state overlapping the consensus peak regions of NIPBL, MED1, SMC1A (with and without CTCF) was calculated. Additionally, that same ratio was calculated for regions where the consensus peaks of NIPBL, MED1 and SMC1A intersected.
Clustering of MED1, SMC1A (no CTCF), SMC1A (with CTCF) and NIPBL data (Fig. 1e)
All MED1, NIPBL, SMC1A (with CTCF) and SMC1A (no CTCF) regions from all cell lines were converted into a binary presence matrix, as in Fig. 1a . The overlap in-between all region categories was calculated using the category with the lowest number of regions as the denominator. The resulting matrix was subjected to hierarchical clustering using euclidian distance and Unweighted Pair Group Method with Arithmetic Mean (UPGMA).
KEGG Pathways (Fig. 2a)
For each cell line, the intersections of the consensus regions for MED1, NIPBL and SMC1A were computed. The selected regions were then annotated using the 
html). Comparison to the hypergeometric distribution was used to
evaluate enrichment of all KEGG pathways within the set of identified genes. All generated p-values were then subjected to a unified FDR correction.
Overlaps with transcription factors (Fig. 3a) The overlap between the intersection of the MED1, NIPBL, and SMC1A consensus regions and the consensus regions of all available ENCODE factors were computed. The reported pairwise overlap is:
Where NNMS,TF is the number of regions where NIPBL, MED1, SMC1A and the ENCODE TF are all present, NNMS is the number of regions where NIPBL, MED1, SMC1A are present, and NTF is the number of regions where the ENCODE TF is present.
DNA motif searches (Fig. 3a)
The regions bearing NIPBL, MED1 and SMC1A were scanned for known human transcription factor binding site models from the HOCOMOCO v9 10 database using the Bioconductor package PWMEnrich (https://www.bioconductor.org/packages/release/bioc/html/PWMEnrich.html).
Lentiviral shRNAs
Lentiviruses were produced according to the TRC1.5 system from Sigma and plasmids and shRNA sequences used are shown in the Supplementary Table S3 . The packaging cell line HEK293T was used to produce lentiviral particles containing the pLKO.1 vectors.
Cells were transfected with 1:3:6 μg DNA respectively composed of packaging vectors pMD2.G (Addgene, #12259) and psPAX2 (Addgene, #12260), as well as the specific shRNA constructs. Transfections were performed with X-tremGENE 9 transfection reagent (Roche), according to manufacturer's instructions. Supernatants were harvested 48h following transfection. Supernatants were filtered and added to recipient cell lines with 8 μg/mL polybrene (SIGMA, H9268), as described on Addgene website. Cells infected with the lentivirus were incubated 24h before selection with puromycin for 48 h. To assess the efficiency of each shRNA, Western blot analyses were performed using antibodies against NIPBL, (Bethyl, A301-779A, 1:1000), MED1 (Bethyl A300-793A, 1:5000), SMC1A
(Bethyl, A300-055A, 1:5000), ERa (Santa Cruz, sc-543x, 1:5000), FOXA1 (Santa Cruz, sc-101058, 1:1000), FOXA2 (Abnova, 89-019-034, 1:1000 ), HNF4A (Santa Cruz, sc8987x, 1:1000), FOSL2 (Santa Cruz, sc-604x, 1:1000), GAPDH (Pierce, PIMA515738, 1:25000) and Vinculin (SIGMA, V9131, 1:50000)..
Cell proliferation assays (Figs 2b and 4a)
Cell proliferation assays were performed on A549, HEPG2 and MCF7 with cells infected with lentiviruses containing the validated shRNA constructs. 1998-2010 (2003) . CTCF  ENCSR000AHD  ENCFF000QLT  MCF-7  EGR1  ENCSR000BUX  ENCFF000QMF  MCF-7  EGR1  ENCSR000BUX  ENCFF000QMC  MCF-7  ELF1  ENCSR000BSS  ENCFF000QMJ  MCF-7  ELF1  ENCSR000BSS  ENCFF000QMK  MCF-7  EP300  ENCSR000BTR  ENCFF000QPK  MCF-7  EP300  ENCSR000BTR  ENCFF000QPP  MCF-7  FOSL2  ENCSR000BUI  ENCFF000QMU  MCF-7  FOSL2  ENCSR000BUI  ENCFF000QMS  MCF-7  FOXM1 ENCSR000BUJ  ENCFF000QMZ  MCF-7  FOXM1 ENCSR000BUJ  ENCFF000QNC  MCF-7  GABPA ENCSR000BUK  ENCFF000QNK  MCF-7  GABPA ENCSR000BUK  ENCFF000QNJ  MCF-7  GATA3  ENCSR000EWV  ENCFF000ZKL  MCF-7  GATA3  ENCSR000EWV  ENCFF000ZKJ  MCF-7  GATA3  ENCSR000EWS  ENCFF000ZKV  MCF-7  GATA3  ENCSR000EWS  ENCFF000ZKT  MCF-7  GATA3  ENCSR000EWS  ENCFF000ZLE  MCF-7  GATA3  ENCSR000BST  ENCFF000QNS  MCF-7  GATA3  ENCSR000BST  ENCFF000QNP  MCF-7 H3K27ac ENCSR000EWR ENCFF000VHD MYC  ENCSR000DMP  ENCFF000RYO  MCF-7  MYC  ENCSR000DMP  ENCFF000RYP  MCF-7  MYC  ENCSR000DMM  ENCFF000RZE  MCF-7  MYC  ENCSR000DMM  ENCFF000RZC  MCF-7  MYC  ENCSR000DMJ  ENCFF000RZL  MCF-7  MYC  ENCSR000DMJ  ENCFF000RZJ  MCF-7  NR2F2  ENCSR000BUY  ENCFF000QOY  MCF-7  NR2F2  ENCSR000BUY  ENCFF000QOV  MCF-7  PML  ENCSR000BUZ  ENCFF000QPW  MCF-7  PML  ENCSR000BUZ  ENCFF000QPV  MCF-7  POLR2A ENCSR000DMT  ENCFF000SBK  MCF-7  POLR2A ENCSR000DMT  ENCFF000SBI  MCF-7  POLR2A ENCSR000DMN  ENCFF000SBP  MCF-7  POLR2A ENCSR000DMN  ENCFF000SBO  MCF-7  POLR2A ENCSR000DMK  ENCFF000SBV  MCF-7  POLR2A ENCSR000DMK  ENCFF000SBY  MCF-7  RAD21  ENCSR000BTQ  ENCFF000QPX  MCF-7  RAD21  ENCSR000BTQ  ENCFF000QQA  MCF-7  REST  ENCSR000BSP  ENCFF000QPH  MCF-7  REST  ENCSR000BSP  ENCFF000QPE  MCF-7  SIN3A  ENCSR000BUM  ENCFF000QQX  MCF-7  SIN3A  ENCSR000BUM  ENCFF000QQU  MCF-7  SRF  ENCSR000BVA  ENCFF000QRE  MCF-7  SRF  ENCSR000BVA  ENCFF000QRH  MCF-7  TAF1  ENCSR000AHF  ENCFF000QRS  MCF-7  TAF1  ENCSR000AHF  ENCFF000QRL  MCF-7  TCF12  ENCSR000BUN  ENCFF000QRV  MCF-7  TCF12  ENCSR000BUN  ENCFF000QRU  MCF-7  TCF7L2 ENCSR000EWT  ENCFF000ZLK  MCF-7  TCF7L2 ENCSR000EWT  ENCFF000ZLM   MCF-7   TEAD4  ENCSR000BUO  ENCFF000QSI  MCF-7  TEAD4  ENCSR000BUO  ENCFF000QSB  MCF-7  ZNF217 ENCSR000EWU  ENCFF000ZLW  MCF-7  ZNF217 ENCSR000EWU  ENCFF000ZLT  MCF-7  FOXA1  SRP044607/SRX747793  SRR1635461  MCF-7  FOXA1  SRP044607/SRX747794  SRR1635462  MCF-7  Control  SRP044607  SRR1635437  MCF-7  Control  SRP044607  SRR1635438  MCF-7  H3K4me1 SRX153145  SRR507786  MCF-7  H3K4me1 SRX153146  SRR507787  MCF-7  H3K4me1 SRX153147  SRR507788 SIN3A  ENCSR000BGL  ENCFF000PPW  HepG2  SIN3A  ENCSR000BGL  ENCFF000PQC  HepG2  SMC3  ENCSR000EDW  ENCFF000XXY  HepG2  SMC3  ENCSR000EDW  ENCFF000XYC  HepG2  SP1  ENCSR000BJX  ENCFF000PQJ  HepG2  SP1  ENCSR000BJX  ENCFF000PQE  HepG2  SP2  ENCSR000BOU  ENCFF000PQL  HepG2  SP2  ENCSR000BOU  ENCFF000PQP  HepG2  SREBF1  ENCSR000EEO  ENCFF000XYE  HepG2  SREBF1  ENCSR000EEO  ENCFF000XYA  HepG2  SREBF1  ENCSR000EEO  ENCFF000XYB  HepG2  SREBF1  ENCSR000EZP  ENCFF000XYK  HepG2  SREBF1  ENCSR000EZP  ENCFF000XYD  HepG2  SREBF1  ENCSR000EZP  ENCFF000XYL  HepG2  SREBF2  ENCSR000EZO  ENCFF000XYM  HepG2  SREBF2  ENCSR000EZO  ENCFF000XYN  HepG2  SREBF2  ENCSR000EZO  ENCFF000XYS  HepG2  SRF  ENCSR000BLV  ENCFF000PQW  HepG2  SRF  ENCSR000BLV  ENCFF000PQU  HepG2  TAF1  ENCSR000BJN  ENCFF000PRD  HepG2  TAF1  ENCSR000BJN  ENCFF000PRB  HepG2  TBP  ENCSR000EEL  ENCFF000XZI  HepG2  TBP  ENCSR000EEL  ENCFF000XZL  HepG2  TCF12  ENCSR000BJG  ENCFF000PRJ  HepG2  TCF12  ENCSR000BJG  ENCFF000PRL  HepG2  TCF7L2  ENCSR000EVQ  ENCFF000XYX  HepG2  TCF7L2  ENCSR000EVQ  ENCFF000XYV  HepG2  TEAD4  ENCSR000BRP  ENCFF000PRQ  HepG2  TEAD4  ENCSR000BRP  ENCFF000PRU  HepG2  USF1  ENCSR000BGM  ENCFF000PSH  HepG2  USF1  ENCSR000BGM  ENCFF000PSA  HepG2  USF2  ENCSR000EEF  ENCFF000XZT  HepG2  USF2  ENCSR000EEF  ENCFF000XZV  HepG2  YY1  ENCSR000BNT  ENCFF000PSE  HepG2  YY1  ENCSR000BNT  ENCFF000PSD   HepG2   ZBTB33  ENCSR000BNA  ENCFF000PSY  HepG2  ZBTB33  ENCSR000BNA  ENCFF000PST  HepG2  ZBTB33  ENCSR000BHR  ENCFF000PSP  HepG2  ZBTB33  ENCSR000BHR  ENCFF000PSW  HepG2  ZBTB7A  ENCSR000BQA  ENCFF000PTI  HepG2  ZBTB7A  ENCSR000BQA  ENCFF000PTF  HepG2  ZEB1  ENCSR000BVN  ENCFF000PTQ  HepG2  ZEB1  ENCSR000BVN  ENCFF000PTO  HepG2  ZNF274  ENCSR000EVR  ENCFF000XZW  HepG2  ZNF274  ENCSR000EVR  ENCFF000XZX   Supplementary Table S2 -List of ChIP-Seq datasets used in the study (A549 cells) Biosample_name Target Experiment Accession A549 Control Data will be provided through GEO upon publication A549 NIPBL Data will be provided through GEO upon publication A549 MED1 Data will be provided through GEO upon publication A549 SMC1A Data will be provided through GEO upon publication A549  ATF3  ENCSR000BPS  ENCFF000MWR  A549  ATF3  ENCSR000BPS  ENCFF000MWV  A549  BCL3  ENCSR000BQH  ENCFF000MXC  A549  BCL3  ENCSR000BQH  ENCFF000MXD  A549  BHLHE40  ENCSR000DYJ  ENCFF000VOD  A549  CEBPB  ENCSR000DYI  ENCFF000VOL  A549  CEBPB  ENCSR000DYI  ENCFF000VON  A549  CEBPB  ENCSR000BUB  ENCFF000MXK  A549  CEBPB  ENCSR000BUB  ENCFF000MXH  A549  Control  ENCSR000DPE  ENCFF001GWE  A549  Control  ENCSR000DNB  ENCFF000RMI  A549  Control  ENCSR000BVQ  ENCFF000NGN  A549  Control  ENCSR000BVQ  ENCFF000NGK  A549  Control  ENCSR000BVQ  ENCFF000NGM  A549  Control  ENCSR000BPN  ENCFF000NGB  A549  Control  ENCSR000BPD  ENCFF000NGH  A549  Control  ENCSR000BNC  ENCFF000NFR  A549  Control  ENCSR000BKZ  ENCFF000NGC  A549  Control  ENCSR000ASS  ENCFF000AHV  A549  Control  ENCSR000ASS  ENCFF000AHM  A549  CREB1  ENCSR000BRC  ENCFF000MXT  A549  CREB1  ENCSR000BRA  ENCFF000MXO  A549  CTCF  ENCSR000DYD  ENCFF000VPF  A549  CTCF  ENCSR000DYD  ENCFF000VPD  A549  CTCF  ENCSR000DPF  ENCFF001GVU  A549  CTCF  ENCSR000DPF  ENCFF001GWB  A549  CTCF  ENCSR000DNA  ENCFF000RMB  A549  CTCF  ENCSR000DNA  ENCFF000RMC  A549  CTCF  ENCSR000BHW  ENCFF000MYJ  A549  CTCF  ENCSR000BHW  ENCFF000MYN  A549  CTCF  ENCSR000AUF  ENCFF000AHW  A549  CTCF  ENCSR000AUF  ENCFF000AHX  A549  E2F6  ENCSR000BTC  ENCFF000MYY  A549  E2F6  ENCSR000BTC  ENCFF000MYX  A549  ELF1  ENCSR000BPT  ENCFF000MZF  A549  ELF1  ENCSR000BPT  ENCFF000MZG  A549  EP300  ENCSR000BPW  ENCFF000NEG  A549  EP300  ENCSR000BPW  ENCFF000NEI  A549  ETS1  ENCSR000BPU  ENCFF000MZO  A549  ETS1  ENCSR000BPU  ENCFF000MZH  A549  FOSL2  ENCSR000BQO  ENCFF000MZW  A549  FOSL2  ENCSR000BQO  ENCFF000MZT  A549  FOXA1  ENCSR000BRD  ENCFF000NAI  A549  FOXA1  ENCSR000BRD  ENCFF000NAH  A549  FOXA2  ENCSR000BRE  ENCFF000NAQ  A549  FOXA2  ENCSR000BRE  ENCFF000NAU  A549  GABPA  ENCSR000BPY  ENCFF000NAY  A549  GABPA  ENCSR000BPY  ENCFF000NBA  A549  GATA3  ENCSR000BTI  ENCFF000NBH  A549  GATA3  ENCSR000BTI  ENCFF000NBM  A549  H2AFZ  ENCSR000AUH  ENCFF000AIK   A549   H2AFZ  ENCSR000AUH  ENCFF000AIJ  A549  H3K27ac  ENCSR000AUI  ENCFF000AKS  A549  H3K27ac  ENCSR000AUI  ENCFF000AKR  A549  H3K27me3  ENCSR000AUK  ENCFF000ALD  A549  H3K27me3  ENCSR000AUK  ENCFF000ALK  A549  H3K36me3  ENCSR000AUL  ENCFF000ALU  A549  H3K36me3  ENCSR000AUL  ENCFF000ALQ  A549  H3K4me1  ENCSR000AUM  ENCFF000AJC  A549  H3K4me1  ENCSR000AUM  ENCFF000AIW  A549  H3K4me2  ENCSR000AVI  ENCFF000AJI  A549  H3K4me2  ENCSR000AVI  ENCFF000AJH  A549  H3K4me3  ENCSR000DPD  ENCFF001EMB  A549  H3K4me3  ENCSR000DPD  ENCFF001EMC  A549  H3K4me3  ENCSR000ASH  ENCFF000AJT  A549  H3K4me3  ENCSR000ASH  ENCFF000AJX  A549  H3K79me2  ENCSR000ATP  ENCFF000AMB  A549  H3K79me2  ENCSR000ATP  ENCFF000AMD  A549  H3K9ac  ENCSR000ASV  ENCFF000AJY  A549  H3K9ac  ENCSR000ASV  ENCFF000AJZ  A549  H3K9me3  ENCSR000AUN  ENCFF000AKK  A549  H3K9me3  ENCSR000AUN  ENCFF000AKG  A549  H4K20me1  ENCSR000AUO  ENCFF000AMF  A549  H4K20me1  ENCSR000AUO  ENCFF000AME  A549  JUND  ENCSR000BRF  ENCFF000NDF  A549  JUND  ENCSR000BRF  ENCFF000NDH  A549  MAX  ENCSR000DYG  ENCFF000VPS  A549  MAX  ENCSR000DYG  ENCFF000VPU  A549  MAX  ENCSR000BTJ  ENCFF000NDP  A549  MAX  ENCSR000BTJ  ENCFF000NDT  A549  MYC  ENCSR000DYC  ENCFF000VOW  A549  MYC  ENCSR000DYC  ENCFF000VOU  A549  NR3C1  ENCSR000BJT  ENCFF000NDD  A549  NR3C1  ENCSR000BJT  ENCFF000NDA  A549  NR3C1  ENCSR000BIO  ENCFF000NCL  A549  NR3C1  ENCSR000BIO  ENCFF000NCO  A549  PBX3  ENCSR000BTN  ENCFF000NEY  A549  PBX3  ENCSR000BTN  ENCFF000NEP  A549  POLR2A  ENCSR000DMZ  ENCFF000RMM  A549  POLR2A  ENCSR000DMZ  ENCFF000RMO  A549  POLR2A  ENCSR000BHH  ENCFF000NEZ  A549  POLR2A  ENCSR000BHH  ENCFF000NFG  A549  POLR2AphosphoS2 ENCSR000DYF  ENCFF000VPZ  A549  POLR2AphosphoS2 ENCSR000DYF  ENCFF000VQB  A549 rabbit-IgG-control ENCSR496AXR ENCFF000VPI A549 rabbit- IgG-control  ENCSR496AXR  ENCFF000VPK  A549  RAD21  ENCSR000DYE  ENCFF000VQI  A549  RAD21  ENCSR000DYE  ENCFF000VQK  A549  RAD21  ENCSR000BUC  ENCFF000NFN  A549  RAD21  ENCSR000BUC  ENCFF000NFL  A549  REST  ENCSR000BQP  ENCFF000NDY  A549  REST  ENCSR000BQP  ENCFF000NDV  A549  SIN3A  ENCSR000BRM  ENCFF000NGY  A549  SIN3A  ENCSR000BRM  ENCFF000NHA  A549  SIX5  ENCSR000BRL  ENCFF000NHG  A549  SIX5  ENCSR000BRL  ENCFF000NHI  A549  SP1  ENCSR000BPE  ENCFF000NHM  A549  SP1  ENCSR000BPE  ENCFF000NHP  A549  TAF1  ENCSR000BPF  ENCFF000NHV   A549   TAF1  ENCSR000BPF  ENCFF000NHY  A549  TCF12  ENCSR000BQQ  ENCFF000NIG  A549  TCF12  ENCSR000BQQ  ENCFF000NID  A549  TEAD4  ENCSR000BUD  ENCFF000NIP  A549  TEAD4  ENCSR000BUD  ENCFF000NIM  A549  USF1  ENCSR000BPV  ENCFF000NJL  A549  USF1  ENCSR000BPV  ENCFF000NJM  A549  USF1  ENCSR000BJB  ENCFF000NJA  A549  USF1  ENCSR000BJB  ENCFF000NJE  A549  YY1  ENCSR000BPM  ENCFF000NJU  A549  YY1  ENCSR000BPM  ENCFF000NJS  A549  ZBTB33  ENCSR000BPZ  ENCFF000NKG  A549  ZBTB33  ENCSR000BPZ  ENCFF000NKB 
